Lykissas E D, Kourounakis P, Brookman S
Pharmacology. 1978;16(4):217-20. doi: 10.1159/000136770.
Pregnenolone-16 alpha-carbonitrile (PCN), administered twice daily p.o. for 3 days at a dose level of 20 mumol/100 g body weight, significantly enhances in vivo binding of 14C-bilirubin and sulfobromophthalein (BSP) to hepatic Y and Z proteins in female Charles River CD rats. 14C-bilirubin-binding to Y protein showed a 61% increase, while binding of the same moiety to the Z protein fraction was augmented by 59%. BSP-binding in vivo demonstrated rises of 114 and 71% in relation to Y and Z proteins, respectively. These data correlate well with previous investigations in which PCN was found to have a beneficial influence on experimentally induced hyperbilirubinemias and, furthermore, there is an indication that phenobarbital, another potent microsomal enzyme inducer, acts via a similar mechanism.
孕烯醇酮 -16α - 腈(PCN),以20微摩尔/100克体重的剂量水平口服给药,每日两次,持续3天,可显著增强雌性查尔斯河CD大鼠体内14C - 胆红素和磺溴酞钠(BSP)与肝脏Y蛋白和Z蛋白的结合。14C - 胆红素与Y蛋白的结合增加了61%,而同一部分与Z蛋白组分的结合增加了59%。体内BSP结合相对于Y蛋白和Z蛋白分别增加了114%和71%。这些数据与之前的研究结果高度相关,在之前的研究中发现PCN对实验性诱导的高胆红素血症有有益影响,此外,有迹象表明,另一种强效微粒体酶诱导剂苯巴比妥也通过类似机制起作用。